P. J. Cagnoni

405 total citations
16 papers, 312 citations indexed

About

P. J. Cagnoni is a scholar working on Oncology, Hematology and Cancer Research. According to data from OpenAlex, P. J. Cagnoni has authored 16 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Hematology and 5 papers in Cancer Research. Recurrent topics in P. J. Cagnoni's work include Hematopoietic Stem Cell Transplantation (5 papers), Cancer Treatment and Pharmacology (4 papers) and Breast Cancer Treatment Studies (4 papers). P. J. Cagnoni is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Cancer Treatment and Pharmacology (4 papers) and Breast Cancer Treatment Studies (4 papers). P. J. Cagnoni collaborates with scholars based in United States, France and Switzerland. P. J. Cagnoni's co-authors include E.J. Shpall, S Matthes, Yago Nieto, SI Bearman, Maureen Ross, R B Jones, Roy B. Jones, Elizabeth J. Shpall, Scott I. Bearman and P D Russ and has published in prestigious journals such as Journal of Clinical Oncology, Bone Marrow Transplantation and Experimental Hematology.

In The Last Decade

P. J. Cagnoni

16 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. J. Cagnoni United States	10	151	90	65	56	34	16	312
M. Maasberg Germany	8	104 0.7×	52 0.6×	44 0.7×	34 0.6×	139 4.1×	15	330
Marna B. McKenzie Canada	9	192 1.3×	90 1.0×	120 1.8×	83 1.5×	93 2.7×	15	478
Kohsuke Yamashita Japan	14	36 0.2×	82 0.9×	27 0.4×	94 1.7×	91 2.7×	33	487
Andrea Keck Austria	9	293 1.9×	102 1.1×	93 1.4×	36 0.6×	151 4.4×	16	484
F D'Alessandro Italy	8	125 0.8×	56 0.6×	19 0.3×	35 0.6×	101 3.0×	16	418
Neil Majithia United States	12	398 2.6×	58 0.6×	147 2.3×	44 0.8×	159 4.7×	19	565
Christian Mozet Germany	13	94 0.6×	63 0.7×	22 0.3×	101 1.8×	132 3.9×	32	359
Maria Badaracco United States	10	60 0.4×	95 1.1×	83 1.3×	17 0.3×	115 3.4×	11	489
L Tschopp Switzerland	8	87 0.6×	46 0.5×	193 3.0×	45 0.8×	103 3.0×	21	371
Veronika Weyer‐Elberich Germany	10	80 0.5×	19 0.2×	19 0.3×	23 0.4×	34 1.0×	32	273

Countries citing papers authored by P. J. Cagnoni

Since Specialization

Citations

This map shows the geographic impact of P. J. Cagnoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. J. Cagnoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. J. Cagnoni more than expected).

Fields of papers citing papers by P. J. Cagnoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. J. Cagnoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. J. Cagnoni. The network helps show where P. J. Cagnoni may publish in the future.

Co-authorship network of co-authors of P. J. Cagnoni

This figure shows the co-authorship network connecting the top 25 collaborators of P. J. Cagnoni. A scholar is included among the top collaborators of P. J. Cagnoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. J. Cagnoni. P. J. Cagnoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Epenetos, A. A., R. L. Ceriani, Jerry A. Peterson, et al.. (2004). Phoenix- A humanised ⁹⁰Y-conjugated monoclonal antibody for the treatment of relapsed breast cancer. Journal of Clinical Oncology. 22(14_suppl). 632–632. 3 indexed citations

Stea, Baldassarre, Tamás Pintér, P. J. Cagnoni, et al.. (2004). Pharmacokinetics (PK) of RSR13 (efaproxiral) predict survival in patients with brain metastases randomized to receive whole brain radiation therapy (WBRT) with or without RSR13 (REACH RT-009). Journal of Clinical Oncology. 22(14_suppl). 1561–1561. 1 indexed citations

Choy, H., Charles Scott, Abdenour Nabid, et al.. (2003). 1080 Induction chemotherapy followed by concurrent RSR13 (Efaproxiral) and trt for patients with locally advanced NSCLC: mature results of a phase II study and comparison with the results from RTOG 94-10. European Journal of Cancer Supplements. 1(5). S323–S323. 1 indexed citations

Cagnoni, P. J., Christian Brandts, Romeo A. Mandanas, et al.. (2001). Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors. Journal of Immunotherapy. 24(4). 384–388. 41 indexed citations

Nieto, Yago, P D Russ, Gregory T. Everson, et al.. (2000). Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation. Bone Marrow Transplantation. 26(1). 109–111. 30 indexed citations

Shpall, Elizabeth J., Ralph Quinones, Robert T. Jones, et al.. (2000). Transplantation of adult and pediatric cancer patients with ex vivo expanded cord blood. Experimental Hematology. 28(7). 88–88. 1 indexed citations

Cagnoni, P. J., et al.. (1999). Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics. Bone Marrow Transplantation. 24(1). 1–4. 69 indexed citations

Nieto, Yago, Maureen Ross, Roberto Gianani, et al.. (1999). Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant. Bone Marrow Transplantation. 23(12). 1323–1324. 7 indexed citations

Bearman, SI, P. J. Cagnoni, E.J. Shpall, et al.. (1999). High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy. Bone Marrow Transplantation. 24(5). 491–495. 4 indexed citations

10.

Nieto, Yago, P. J. Cagnoni, SI Bearman, et al.. (1999). Acute encephalopathy: a new toxicity associated with high-dose paclitaxel.. PubMed. 5(3). 501–6. 35 indexed citations

11.

Shpall, E.J., L. Hami, Roy B. Jones, et al.. (1998). TRANSPLANTATION OF CANCER PATIENTS RECEIVING HIGH DOSE CHEMOTHERAPY WITH EX VIVO EXPANDED CORD BLOOD CELLS. 92(10). 16 indexed citations

12.

Bolwell, BJ, et al.. (1997). High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4–9 involved axillary lymph nodes. Bone Marrow Transplantation. 20(11). 931–937. 48 indexed citations

13.

Cagnoni, P. J.. (1996). Mobilization and selection of CD34-positive hematopoietic progenitors. Blood Reviews. 10(1). 1–7. 13 indexed citations

14.

Cagnoni, P. J., Elizabeth J. Shpall, Scott I. Bearman, et al.. (1996). Paclitaxel-containing high-dose chemotherapy: the University of Colorado experience.. PubMed. 23(6 Suppl 15). 43–8. 12 indexed citations

15.

Cagnoni, P. J., Roy B. Jones, Scott I. Bearman, et al.. (1996). Use of amifostine in bone marrow purging.. PubMed. 23(4 Suppl 8). 44–8. 16 indexed citations

16.

Bearman, Scott I., et al.. (1996). High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer.. PubMed. 23(1 Suppl 2). 60–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact